Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2020

01-04-2020 | Endoscopy | Editorial

GI Endoscopy Sedation in Patients with Cirrhosis: Routine or Unpredictable?

Authors: Basavana Goudra, Preet Mohinder Singh

Published in: Digestive Diseases and Sciences | Issue 4/2020

Login to get access

Excerpt

Sedating patients with cirrhosis undergoing gastrointestinal (GI) endoscopy procedures poses unique challenges. While the derangement of synthetic and metabolic functions of the liver affects the pharmacokinetics of the sedative medications, the degree of encephalopathy can influence the pharmacodynamic properties of these drugs. Moreover, since the severity of ascites can compromise respiration, drainage is occasionally needed before the procedure. An increased frequency of abnormal gastroesophageal reflux in patients with cirrhosis is a possible effect of esophageal dysmotility. Impairment of gastric emptying and accommodation results in early satiety [1]. As a result of gastroparesis, patients with cirrhosis experience symptoms such as postprandial abdominal pain, nausea, and vomiting [2]. Cardiac afterload is reduced due to a fall in the peripheral vascular resistance. …
Literature
2.
go back to reference Verne GN, Soldevia-Pico C, Robinson ME, Spicer KM, Reuben A. Autonomic dysfunction and gastroparesis in cirrhosis. J Clin Gastroenterol. 2004;38:72–76.CrossRef Verne GN, Soldevia-Pico C, Robinson ME, Spicer KM, Reuben A. Autonomic dysfunction and gastroparesis in cirrhosis. J Clin Gastroenterol. 2004;38:72–76.CrossRef
3.
go back to reference MacGilchrist AJ, Birnie GG, Cook A, et al. Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis. Gut. 1986;27:190–195.CrossRef MacGilchrist AJ, Birnie GG, Cook A, et al. Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis. Gut. 1986;27:190–195.CrossRef
4.
go back to reference Shelly MP, Dixon JS, Park GR. The pharmacokinetics of midazolam following orthotopic liver transplantation. Br J Clin Pharmacol. 1989;27:629–633.CrossRef Shelly MP, Dixon JS, Park GR. The pharmacokinetics of midazolam following orthotopic liver transplantation. Br J Clin Pharmacol. 1989;27:629–633.CrossRef
5.
go back to reference Goudra B, Singh P. Remimazolam: the future of its sedative potential. Saudi J Anaesth. 2014;8:388.CrossRef Goudra B, Singh P. Remimazolam: the future of its sedative potential. Saudi J Anaesth. 2014;8:388.CrossRef
7.
go back to reference Suh SJ, Yim HJ, Yoon EL, et al. Is propofol safe when administered to cirrhotic patients during sedative endoscopy? Korean J Intern Med. 2014;29:57–65.CrossRef Suh SJ, Yim HJ, Yoon EL, et al. Is propofol safe when administered to cirrhotic patients during sedative endoscopy? Korean J Intern Med. 2014;29:57–65.CrossRef
10.
go back to reference Goudra B, Nuzat A, Singh PM, Gouda GB, Carlin A, Manjunath AK. Cardiac arrests in patients undergoing gastrointestinal endoscopy: a retrospective analysis of 73,029 procedures. Saudi J Gastroenterol. 2015;21:400–411.CrossRef Goudra B, Nuzat A, Singh PM, Gouda GB, Carlin A, Manjunath AK. Cardiac arrests in patients undergoing gastrointestinal endoscopy: a retrospective analysis of 73,029 procedures. Saudi J Gastroenterol. 2015;21:400–411.CrossRef
Metadata
Title
GI Endoscopy Sedation in Patients with Cirrhosis: Routine or Unpredictable?
Authors
Basavana Goudra
Preet Mohinder Singh
Publication date
01-04-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05949-0

Other articles of this Issue 4/2020

Digestive Diseases and Sciences 4/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.